Chapter 17. Chronic Obstructive Pulmonary Disease MTM Data Set
Which host factor can influence the risk of developing COPD following exposure to environmental risk factors?
c. Occupational dusts and chemicals
d. Airway hyperresponsiveness
Which factor is indicative of a patient who is “high risk” for future COPD exacerbations?
a. Daily use of both long-acting beta2-agonist and anticholinergic bronchodilator.
b. COPD Assessment Test (CAT) score of 12.
c. Grade 3 airflow limitation.
d. A history of 2 COPD exacerbations in the previous 12 months.
Which directive is a component of the goal of risk reduction for COPD patients?
a. Prevent and treat exacerbations.
b. Improve exercise tolerance.
c. Use quick-relief medication per schedule.
d. Reduce quick-relief medication use.
Which term can be defined, in living-room language, as the “total amount of air you can breathe out in 1 second?”
Which information would be appropriate to include in the MAP for a COPD patient?
a. Tiotropium is a controller inhaler that may be used as needed to treat shortness of breath.
b. Use your tiotropium inhaler once every morning as prescribed (even on the days you wake up feeling well).
c. Fluticasone/salmeterol is a quick-relief inhaler that may be used as needed to treat shortness of breath.
d. If you experience shortness of breath during the day, use your fluticasone/salmeterol inhaler as prescribed for quick relief of your symptoms.
Which symptom requires IMMEDIATE referral to a physician?
a. Shortness of breath after climbing several flights of stairs that is relieved upon ...